Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
59
SYRE Quote, Financials, Valuation and Earnings
Last price:
$33.11
Seasonality move
:
14.35%
Day range:
$32.79 - $34.10
52-week range:
$10.91 - $35.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
701.12x
P/B ratio:
5.63x
Volume:
292K
Avg. volume:
814.3K
1-year change:
41.6%
Market cap:
$2.6B
Revenue:
--
EPS (TTM):
-$2.18
Earnings Data
Next earnings date for SYRE
Feb 26
2026
Most recent earnings per share
-$0.18
Beat by $0.56
(Nov 4/2025)
Consensus Estimate
-$0.74
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SYRE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | -- | -- | -- | -$0.79 | -- |
| 11/04/2025 | Q3 | -- | -- | -$0.18 | -$0.74 | $0.56 |
| 08/05/2025 | Q2 | -- | -- | -$0.60 | -$0.71 | $0.11 |
| 05/08/2025 | Q1 | -- | -- | -$0.60 | -$0.84 | $0.24 |
| 02/27/2025 | Q4 | $2.1M | -- | -$0.79 | -$0.94 | $0.15 |
| 11/07/2024 | Q3 | -- | -- | -$1.06 | -$0.86 | -$0.19 |
| 08/07/2024 | Q2 | $2.9M | -- | -$0.59 | -$0.91 | $0.32 |
| 05/09/2024 | Q1 | -- | -- | -$0.72 | -$1.08 | $0.36 |
| 02/29/2024 | Q4 | $220K | -- | $11.58 | -$0.83 | $12.41 |
| 11/09/2023 | Q3 | -- | -- | -$9.34 | -- | -- |
| 06/30/2023 | Q2 | -- | $688K | -$56.79 | -- | -- |
| 03/31/2023 | Q1 | -- | $198K | -$4.89 | -- | -- |
| 12/31/2022 | Q4 | -- | $168K | -$7.20 | -- | -- |
| 09/30/2022 | Q3 | -- | $174K | -$4.84 | -- | -- |
| 06/30/2022 | Q2 | -- | $625K | -$6.79 | -- | -- |
| 03/31/2022 | Q1 | -- | $1.4M | -$9.26 | -- | -- |
| 12/31/2021 | Q4 | -- | $3.6M | -$10.36 | -- | -- |
| 09/30/2021 | Q3 | -- | $1.4M | -$7.72 | -- | -- |
| 06/30/2021 | Q2 | -- | $13.7M | -$2.60 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$6.94 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$11.84 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$7.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$10.11 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$14.15 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$18.48 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$16.40 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$13.72 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$14.79 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$15.50 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$13.55 | -- | -- |
| 06/30/2018 | Q2 | -- | $2.4M | -$11.43 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.5M | -$12.17 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.5M | -$9.75 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.3M | -$12.00 | -- | -- |
| 06/30/2017 | Q2 | -- | $1.5M | -$11.75 | -- | -- |
| 03/31/2017 | Q1 | -- | $982K | -$11.75 | -- | -- |
| 12/31/2016 | Q4 | -- | $1.2M | -$10.25 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.1M | -$11.75 | -- | -- |
| 06/30/2016 | Q2 | -- | $1.4M | -$11.50 | -- | -- |
| 03/31/2016 | Q1 | -- | $859K | -$177.50 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.6M | -$7.29 | -- | -- |
Spyre Therapeutics, Inc. Earnings Questions
-
How Much did Spyre Therapeutics, Inc. Generate in Revenue Last Quarter?
Spyre Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Spyre Therapeutics, Inc. Beat Earnings Last Quarter?
Spyre Therapeutics, Inc. announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.74 per share.
-
Is Spyre Therapeutics, Inc. Profitable?
Spyre Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Spyre Therapeutics, Inc. EPS Next Year?
Spyre Therapeutics, Inc.'s earnings are forecast to decrease from -$3.18 per share to -$4.30 per share next year representing a decrease of -32.69%.
-
When is Spyre Therapeutics, Inc.'s Earnings Date?
Spyre Therapeutics, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
